Charles Schwab
ANGO icon

Charles Schwab’s AngioDynamics ANGO Stock Holding History

Charles Schwab’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.87M Buy
374,029
+39,326
+12% +$448K ﹤0.01% 2494
2026
Q1 		$3.81M Buy
334,703
+1,797
+0.5% +$19.5K ﹤0.01% 2510
2025
Q4 		$4.27M Sell
332,906
-244
-0.1% -$3.01K ﹤0.01% 2519
2025
Q3 		$3.72M Sell
333,150
-2,222
-0.7% -$21.4K ﹤0.01% 2555
2025
Q2 		$3.33M Buy
335,372
+14,463
+5% +$142K ﹤0.01% 2501
2025
Q1 		$3.01M Sell
320,909
-8,181
-2% -$86K ﹤0.01% 2479
2024
Q4 		$3.01M Buy
329,090
+2,270
+0.7% +$16.7K ﹤0.01% 2547
2024
Q3 		$2.54M Buy
326,820
+11,599
+4% +$83.8K ﹤0.01% 2637
2024
Q2 		$1.91M Sell
315,221
-3,157
-1% -$19.5K ﹤0.01% 2719
2024
Q1 		$1.87M Buy
318,378
+14,233
+5% +$84.6K ﹤0.01% 2610
2023
Q4 		$2.38M Sell
304,145
-2,468
-0.8% -$17.1K ﹤0.01% 2558
2023
Q3 		$2.24M Buy
306,613
+3,694
+1% +$30.7K ﹤0.01% 2562
2023
Q2 		$3.16M Buy
302,919
+13,493
+5% +$130K ﹤0.01% 2411
2023
Q1 		$2.99M Sell
289,426
-529
-0.2% -$6.77K ﹤0.01% 2414
2022
Q4 		$3.99M Buy
289,955
+5,762
+2% +$80.2K ﹤0.01% 2328
2022
Q3 		$5.82M Buy
284,193
+9,369
+3% +$206K ﹤0.01% 2133
2022
Q2 		$5.32M Sell
274,824
-6,400
-2% -$131K ﹤0.01% 2164
2022
Q1 		$6.06M Buy
281,224
+12,174
+5% +$276K ﹤0.01% 2186
2021
Q4 		$7.42M Buy
269,050
+5,143
+2% +$142K ﹤0.01% 2152
2021
Q3 		$6.85M Buy
263,907
+3,257
+1% +$87.1K ﹤0.01% 2225
2021
Q2 		$7.07M Buy
260,650
+5,751
+2% +$140K ﹤0.01% 2184
2021
Q1 		$5.96M Buy
254,899
+6,512
+3% +$132K ﹤0.01% 2207
2020
Q4 		$3.81M Buy
248,387
+6,013
+2% +$76.3K ﹤0.01% 2349
2020
Q3 		$2.92M Sell
242,374
-5,558
-2% -$52.8K ﹤0.01% 2344
2020
Q2 		$2.52M Buy
247,932
+15,727
+7% +$162K ﹤0.01% 2338
2020
Q1 		$2.42M Buy
232,205
+6,379
+3% +$80.1K ﹤0.01% 2195
2019
Q4 		$3.62M Buy
225,826
+4,294
+2% +$65.6K ﹤0.01% 2192
2019
Q3 		$4.08M Buy
221,532
+7,978
+4% +$156K ﹤0.01% 2077
2019
Q2 		$4.21M Sell
213,554
-21,887
-9% -$446K ﹤0.01% 2060
2019
Q1 		$5.38M Buy
235,441
+8,689
+4% +$189K ﹤0.01% 1952
2018
Q4 		$4.57M Sell
226,752
-42,940
-16% -$889K ﹤0.01% 1953
2018
Q3 		$5.86M Sell
269,692
-16,505
-6% -$367K ﹤0.01% 1960
2018
Q2 		$6.37M Sell
286,197
-20,085
-7% -$411K ﹤0.01% 1875
2018
Q1 		$5.28M Sell
306,282
-54,580
-15% -$910K ﹤0.01% 1910
2017
Q4 		$6M Sell
360,862
-2,416
-0.7% -$41.2K ﹤0.01% 1825
2017
Q3 		$6.21M Buy
363,278
+23,306
+7% +$392K 0.01% 1762
2017
Q2 		$5.51M Buy
339,972
+105,414
+45% +$1.67M 0.01% 1758
2017
Q1 		$4.07M Buy
234,558
+94,282
+67% +$1.58M ﹤0.01% 1876
2016
Q4 		$2.37M Buy
140,276
+5,082
+4% +$84.8K ﹤0.01% 2113
2016
Q3 		$2.37M Buy
135,194
+33,485
+33% +$543K ﹤0.01% 2056
2016
Q2 		$1.46M Buy
101,709
+1,344
+1% +$16.8K ﹤0.01% 2209
2016
Q1 		$1.23M Buy
100,365
+1,632
+2% +$18K ﹤0.01% 2252
2015
Q4 		$1.2M Sell
98,733
-34,220
-26% -$421K ﹤0.01% 2307
2015
Q3 		$1.75M Buy
132,953
+5,505
+4% +$83.1K ﹤0.01% 2145
2015
Q2 		$2.09M Buy
127,448
+9,978
+8% +$166K ﹤0.01% 2072
2015
Q1 		$2.09M Buy
117,470
+3,364
+3% +$62.5K ﹤0.01% 2029
2014
Q4 		$2.17M Sell
114,106
-56,823
-33% -$963K ﹤0.01% 1963
2014
Q3 		$2.35M Buy
170,929
+1,423
+0.8% +$20.3K ﹤0.01% 1870
2014
Q2 		$2.77M Sell
169,506
-448
-0.3% -$6.49K ﹤0.01% 1798
2014
Q1 		$2.68M Buy
169,954
+1,680
+1% +$27.4K ﹤0.01% 1786
2013
Q4 		$2.89M Buy
168,274
+105,646
+169% +$1.63M 0.01% 1675
2013
Q3 		$869K Buy
62,628
+6,530
+12% +$77K ﹤0.01% 2276
2013
Q2 		$638K Buy
+56,098
New +$597K ﹤0.01% 2400

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab's ANGO Position: Q2 2026 in Review

Charles Schwab increased its AngioDynamics (ANGO) stake by 12% in Q2 2026, buying an estimated $448K and bringing the position to 374,029 shares worth $4.87M. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

Charles Schwab first reported a position in ANGO in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.42M in Q4 2021. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Charles Schwab held 374,029 shares of AngioDynamics worth $4.87M as of Q2 2026.
  • Charles Schwab bought 39,326 AngioDynamics shares in Q2 2026, an estimated $448K.
  • AngioDynamics made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2494 holding.
  • Charles Schwab first reported a position in AngioDynamics in Q2 2013 and has held it in 53 quarters since.
  • Charles Schwab's AngioDynamics position peaked at $7.42M in Q4 2021.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.